Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kehuang capsules for rosacea
ChiCTR2200060254Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Hunan University of Chinese Medicine
- Start
- Jun 2022
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Kehuang Capsules in rosacea (2 arms), sponsored by The Second Affiliated Hospital of Hunan University of Chinese Medicine. Primary endpoint: Clinical efficacy. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
Kehuang Capsules
03
Conditions
rosacea
Beyond the preview
Go deeper on ChiCTR2200060254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060254.